Grifols SA Files Routine 6-K Report

Ticker: GIKLY · Form: 6-K · Filed: Apr 18, 2024 · CIK: 1438569

Grifols SA 6-K Filing Summary
FieldDetail
CompanyGrifols SA (GIKLY)
Form Type6-K
Filed DateApr 18, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-k, foreign-private-issuer

TL;DR

Grifols filed a standard 6-K, no major news.

AI Summary

Grifols, S.A. filed a Form 6-K on April 18, 2024, to report other relevant information. The filing is a standard report for foreign private issuers and does not contain specific financial details or material events beyond its routine nature.

Why It Matters

This filing indicates Grifols, S.A. is meeting its reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.

Risk Assessment

Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information or financial disclosures.

Key Players & Entities

  • Grifols, S.A. (company) — Registrant
  • 001-35193 (company) — SEC File Number
  • 20240418 (date) — Filing Date

FAQ

What type of filing is this for Grifols, S.A.?

This is a Form 6-K, which is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.

What is the filing date of this report?

The filing date is April 18, 2024.

What is Grifols, S.A.'s principal executive office address?

Grifols, S.A.'s principal executive office is located at Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, 08174 Barcelona, Spain.

Does Grifols, S.A. file annual reports under Form 20-F or 40-F?

The filing indicates that Grifols, S.A. files annual reports under Form 20-F.

What is the SIC code for Grifols, S.A.?

The Standard Industrial Classification (SIC) code for Grifols, S.A. is 2834, Pharmaceutical Preparations.

Filing Stats: 388 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2024-04-18 14:31:53

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. Grifols, S.A. By: /s/ David I. Bell Name: David I. Bell Title: Authorized Signatory Date: April 18, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.